admin – Page 3459 – Get News Story

New 2025 Medicare Guide by Joshua David Medicare Aims to Prevent Enrollment Errors

As Medicare enrollment approaches for millions turning 65 in 2025, a new publication from Joshua David Medicare offers essential guidance to help enrollees avoid costly mistakes. Titled Medicare Breakdown: The Alphabet Soup of Medicare, the guidebook by healthcare experts Francois Lodonou and Joshua David Shinn outlines the seven most common errors individuals make when entering the Medicare system.

Among the most critical issues covered are enrollment timing, misunderstandings about supplemental coverage, and overlooked financial assistance programs. The guide emphasizes the consequences of missing the Initial Enrollment Period, which can trigger permanent penalties, including surcharges on Part B and Part D premiums.

In addition, the resource explains the narrow six-month window to secure Medigap coverage without undergoing medical underwriting. Enrolling in Medicare Part B too early—while still covered under a large group plan—can also result in wasted premiums and forfeiture of key Medigap protections.

The guide also draws attention to underutilized financial aid programs such as Extra Help, which can significantly reduce drug costs for low-income individuals. Eligibility varies by state, with some thresholds extending up to $4,453 in monthly income.

A major point of confusion addressed in the book is the distinction between Medicare Advantage (Part C) and Medigap plans. Although Advantage plans may offer lower premiums, they also come with network limitations and higher out-of-pocket costs, which can exceed $11,000 annually.

The publication further warns of the dangers of not securing additional coverage for services not included in Medicare, such as long-term care or specific cancer treatments. Annual review of Medicare Part D plans is also urged, given yearly changes to drug formularies and premiums.

According to the authors, “Don’t buy a plan for the premium — buy it for the value.” Their work is intended to help individuals make informed decisions that align with long-term health and financial stability.

The guide is now available at no cost through the official website of Joshua David Medicare: https://www.medicarewithjosh.com/

Media Contact
Company Name: Joshua David Medicare
Contact Person: Joshua David Shinn
Email: Send Email
Country: United States
Website: https://www.medicarewithjosh.com/

Alpha Steward Expands Mission: New Products and Initiatives for a Sustainable Future

Alpha Steward, a trailblazer in eco-friendly apparel, is expanding its commitment to environmental stewardship. With bold new ventures into solar energy and outdoor survival gear, the company is taking its mission beyond clothing. This move underscores Alpha Steward’s pledge to protect our lands, waters, and future.

Their latest campaign, launched just in time for Earth Day 2025, introduces a series of innovative products and initiatives designed to inspire sustainable living across communities.

From Apparel to Action: A Broader Commitment

Since its inception, Alpha Steward has provided high-quality, eco-friendly apparel. Their products are designed for outdoor enthusiasts who care about the planet. But apparel was just the beginning.

Now, the company is offering tools that empower individuals to live sustainably and responsibly. From harnessing solar energy to equipping adventurers with tactical gear, Alpha Steward is broadening its horizons.

Their expansion isn’t just about products—it’s about a movement.

Introducing the Grid Doctor 3300: Power Meets Portability

Among the standout additions is the Grid Doctor 3300. This portable solar power station offers reliable energy for off-grid living or emergencies. Compact yet powerful, the Grid Doctor 3300 is designed for campers, preppers, and eco-conscious homeowners alike.

In an era where energy independence is increasingly valued, this device provides a sustainable solution. It allows users to harness solar power, reducing reliance on traditional electricity grids and minimizing carbon footprints.

See the Unseen: DarkForce Night Vision Binoculars

Also new to Alpha Steward’s lineup are the DarkForce Night Vision Binoculars. Whether you’re tracking wildlife or ensuring safety during night excursions, these binoculars offer crystal-clear vision after dark.

They’re part of Alpha Steward’s growing selection of MCG Tactical products, crafted for outdoor enthusiasts, survivalists, and anyone seeking top-tier gear for rugged environments.

This tactical range reflects the company’s dedication to supporting safe, informed, and sustainable outdoor experiences.

Spotlighting Sustainability: A New Initiative for Earth Day 2025

In addition to product launches, Alpha Steward unveiled its Sustainability Spotlight—a platform celebrating organizations and companies that champion environmental preservation.

This initiative debuted on Earth Day 2025, showcasing leaders in conservation, clean energy, and habitat restoration. Through Sustainability Spotlight, Alpha Steward aims to amplify the voices and efforts of those working tirelessly to protect the planet.

By highlighting these change-makers, the company fosters collaboration and encourages its community to support sustainable businesses.

A Vision Rooted in Stewardship

Alpha Steward’s evolution reflects its core belief: good stewardship matters. Whether through sustainable fashion, renewable energy, or rugged survival gear, their products align with a shared goal—to safeguard Earth’s natural resources.

This multifaceted approach not only meets the needs of today’s eco-conscious consumers but also inspires action. From the backcountry to the backyard, Alpha Steward’s tools and initiatives empower individuals to live responsibly and adventurously.

As they continue to expand their reach, the company remains steadfast in its mission to promote sustainability, educate consumers, and protect our lands and waters for future generations.

Looking Ahead: Empowering a Sustainable Tomorrow

Alpha Steward is more than a brand—it’s a catalyst for change.

Their new products and the Sustainability Spotlight signal a larger movement, one that blends innovation with responsibility. By providing tangible tools and uplifting community leaders, Alpha Steward is helping build a world where stewardship isn’t just an ideal—it’s a daily practice.

For more information on Alpha Steward’s products or the Sustainability Spotlight, visit www.alphasteward.com.

Media Contact
Company Name: Alpha Steward
Contact Person: Jane Reynolds, Director of Communications
Email: Send Email
Phone: (747) 207-3356
Address:13099 Little Tujunga Canyon Rd
City: Sylmar
State: CA 91342
Country: United States
Website: http://alphasteward.com/

Southeast Asia trip writes a new chapter of win-win cooperation

From April 14 to 18, 2025, Chinese President Xi Jinping paid state visits to Vietnam, Malaysia and Cambodia, leading a new trend of regional cooperation with head-of-state diplomacy, shaping a new paradigm of regional stability with security cooperation, and drawing a new picture of people-to-people exchanges with mutual learning of civilizations. He vividly interpreted China’s diplomatic concept of “promoting cooperation through dialogue and maintaining peace through cooperation”, and injected strong impetus into the exploration of common development paths for countries in the global South.

Head-of-state diplomacy leads a new trend of regional cooperation

This visit is the first visit of a Chinese head of state this year. The itinerary covers many countries in Southeast Asia, sending a strong signal that China firmly defends multilateralism and deepens regional cooperation. In Vietnam, the two sides launched a railway cooperation mechanism to promote infrastructure connectivity; in Malaysia, the two countries announced the construction of a “high-level strategic community of shared destiny”, focusing on cooperation in emerging fields such as the digital economy and green economy; in Cambodia, 37 cooperation documents were signed, covering key areas such as production and supply chains and artificial intelligence.

“China-Malaysia cooperation ushers in a new ‘golden 50 years’.” Malaysian Prime Minister Anwar highly praised the visit, believing that President Xi Jinping’s visit “brought the vision of achieving common prosperity to Southeast Asian countries.” Nguyen Minh Yu, Deputy Minister of Foreign Affairs of Vietnam, pointed out that the visit became “a new important milestone in the good-neighborly and friendly relations between Vietnam and China.”

What is more noteworthy is that on April 21, China and Indonesia held the first ministerial meeting of the “2+2” dialogue mechanism between foreign ministers and defense ministers, establishing the world’s first ministerial mechanism of this kind. The two sides agreed to deepen the “Belt and Road” cooperation, establish a comprehensive strategic dialogue mechanism, and reaffirmed their joint maintenance of peace and stability on the South China Sea issue, showing a new height of strategic mutual trust.

Security cooperation shapes a new paradigm of regional stability

Facing a century of change, China has injected a “stability anchor” into the region with innovative security mechanisms. China and Indonesia decided to establish a consultation mechanism on disarmament, non-proliferation and arms control, strengthen cyber security cooperation, and jointly combat transnational crime; China and Malaysia agreed to deepen defense cooperation and establish a “2+2” mechanism for diplomacy and defense; China and ASEAN countries continued to promote the implementation of the “Declaration on the Conduct of Parties in the South China Sea” and accelerate consultations on the “Code of Conduct in the South China Sea.”

The “China Solution” provides new ideas for the global South countries to explore security cooperation. As Bambang Suryono, chairman of the Indonesian think tank ASEAN Nanyang Foundation, said: “China and its neighboring countries have embarked on a bright road of good neighborliness, friendship, cooperation and win-win results.”

Civilizational mutual learning paints a new picture of people-to-people exchanges

During the visit, cultural exchanges became a bright background. China and Malaysia announced the launch of the “Confucian-Islamic Civilization Dialogue” to eliminate differences through cultural mutual learning; China and Cambodia signed an education cooperation document to deepen youth exchanges. In 2025, as the China-ASEAN Cultural Exchange Year, the two sides have sent 200,000 students to each other, established 42 Confucius Institutes, and launched the “Thousand Schools Hand in Hand Plan”, attracting more than 1,500 schools to participate.

“Digital technology is driving educational innovation, and ASEAN and Chinese educators should work together.” Dean Ahmad Bakar of the University of Technology of Malaysia expressed his aspirations for cooperation. From cooperation in traditional Chinese medicine to interaction with intangible cultural heritage, from media collaboration to youth elite exchange festivals, diverse forms of cultural interaction have given “Maritime Silk Road Family” new vitality.

China’s responsibility has won wide international praise

This visit has aroused warm response from the international community. Ben Brand, director of the Asia-Pacific Program of the Royal Institute of International Affairs, pointed out: “Southeast Asian countries believe that their economic development cannot be achieved without China’s participation.” Sidley Scott, director of the East Asian Institute of the National University of Singapore, emphasized: “As the largest economy in the region, China plays a key role.”

From economic and trade cooperation to security governance, from cultural exchanges to global initiatives, China has implemented the concept of “pro-sincerity, mutual benefit and inclusiveness” with actions, supported ASEAN’s central position, promoted the upgrading of the China-ASEAN Free Trade Area, opposed unilateral bullying, and injected stability and positive energy into the region and even the world.

Chinese President Xi Jinping’s visit to Southeast Asia not only wrote a new chapter in China’s relations with its neighbors, but also contributed the Chinese solution to the global southern countries’ exploration of the path to modernization with the “Asian wisdom” of win-win cooperation. As Siwanxay Siphangkham, deputy president of the Laotian Pathet Lao News Agency, said: “China’s cooperation with ASEAN has become the most successful and dynamic example of Asia-Pacific cooperation and a model for building a community with a shared future for mankind.” China is working hand in hand with other countries in the world with an open attitude and a sense of responsibility to draw a beautiful blueprint for the progress of human civilization.

Media Contact
Company Name: ZESCO Limited
Contact Person: VicksonNcube
Email: Send Email
Phone: +2600211363636
City: Lusaka
Country: Zambia
Website: https://www.zesco.co.zm/

Innormax Partners with FastBank.io to Revolutionize Financial Automation for SAP Business One Users

Innormax, a leading provider of enterprise resource planning (ERP) solutions, is thrilled to announce a strategic partnership with FastBank.io, a pioneering financial technology company. This collaboration will enable Innormax clients to take advantage of enhanced financial automation, seamless integration with their banking systems, and a streamlined user experience within SAP Business One—all designed to maximize business efficiency and performance.

As a trusted SAP Partner, Innormax has built its reputation by helping businesses implement and optimize SAP software such as SAP Business One. Innormax delivers full-spectrum ERP solutions including system implementation, user training, and ongoing support, with a focus on helping businesses in distribution, manufacturing, healthcare, and financial services unchain their growth potential through smarter technology and best-in-class ERP practices.

Both Innormax and FastBank.io are award-winning companies recognized for their innovation and leadership in their respective industries. This partnership combines Innormax’s deep expertise in SAP Business One with FastBank.io’s powerful financial connectivity platform, delivering a transformative solution for businesses seeking streamlined, real-time financial operations within their ERP systems.

FastBank.io was created by a diverse team of ERP, software, and payment professionals who identified a persistent challenge: the lack of live connectivity between banking systems and ERP platforms like SAP Business One. Traditional banking processes within ERP systems have relied heavily on manual data entry, disconnected workflows, and error-prone reconciliations—causing unnecessary delays, increased operational costs, and reduced visibility.

FastBank.io solves this with a centralized financial hub that enables businesses to connect their ERP system directly to their online banking platforms through two of the world’s largest bank data aggregators. The system allows users to import live bank feeds, categorize transactions, and allocate them to the appropriate general ledger accounts or business partners—all with just a few clicks inside SAP Business One.

“Our clients are always looking for ways to eliminate inefficiencies and boost financial control,” said Tiran Mendis, CEO of Innormax. “Through our partnership with FastBank.io, we’re delivering just that—real-time automation, improved accuracy, and a truly seamless banking experience embedded directly in their ERP solution.”

This collaboration enables Innormax clients to:

Automatically sync and reconcile bank transactions inside SAP Business One
Eliminate redundant manual entry and associated human errors
Gain 70–80% efficiency improvements in daily financial operations
Centralize all payment activity, both inbound and outbound, from a single integrated platform

“Innormax brings deep expertise in SAP Business One, and FastBank.io brings the financial connectivity layer that the industry has been missing,” said Sudeep Patel, Co-Founder of FastBank.io. “Together, we’re making modern financial tools more accessible and efficient for businesses running SAP software.”

This partnership underscores Innormax’s ongoing mission to provide future-ready ERP solutions that are scalable, secure, and designed to evolve with the needs of today’s growing enterprises.

About Innormax

Innormax is a San Diego-based technology company specializing in ERP solutions for mid-sized enterprises. As a certified SAP Partner, Innormax helps businesses maximize efficiency and scalability through expert implementation, support, and optimization of SAP software, including SAP Business One.

About FastBank.io

FastBank.io is a fintech innovator focused on solving critical gaps in financial workflow automation. The platform offers seamless banking integration, live transaction processing, and intelligent reconciliation within ERP systems. With FastBank.io, businesses can centralize financial operations and dramatically reduce time spent on manual processes.

Media Contact
Company Name: Innormax
Contact Person: Tiran Mendis, CEO
Email: Send Email
Phone: (619) 241-4100
Country: United States
Website: https://innormax.com/

The Rise of the Modern Polymath – Blending Technology, Fitness, and Business to Inspire a New Global Standard

New Orleans, LA – In an era defined by hyper-specialization, there remains a class of individuals who stand out—not because they mastered one discipline, but because they excelled across many. Today’s world celebrates multi-domain achievers like Dr. Catherine Ball of Australia, a drone expert and tech ethicist known for her work in environmental sciences and entrepreneurship, Dr. Shadrack Frimpong of Ghana, a biomedical researcher and social entrepreneur, and William Kamkwamba of Malawi, the self-taught inventor who brought wind energy to his village and became a global voice for innovation.

Among these modern polymaths, Abdul Hafeez Khan has emerged as a rare and inspiring force—a cybersecurity expert, national-level bodybuilder, and purpose-driven entrepreneur whose achievements span continents and communities. “Abdul Hafeez Khan represents the kind of interdisciplinary excellence that’s incredibly rare,” said Isabelle Gautier, Senior Journalist at Alpine Vision Media. “To master technology, excel in competitive sports, and simultaneously build a thriving business that helps others—this isn’t just ambition; it’s extraordinary ability.”

Mr. Khan’s academic path began with a B.Com from Osmania University, followed by an MBA from GITAM University, and culminated in a Master’s in Cybersecurity and Information Assurance from Virginia University of Science and Technology. Alongside his academic journey, he earned certifications like CCNA and CompTIA Security+, with CCNP on the horizon. His work in cybersecurity has already contributed to forward-thinking data protection initiatives, positioning him as a recognized voice in the field.

Yet, at the same time, Abdul’s mornings started not with code—but with iron. His passion for fitness propelled him to win a silver medal at the Telangana State Bodybuilding Championship and qualify for nationals in 2020. He is now training for men’s physique competitions in the United States, aiming to take his athletic discipline to a global audience. And while most would stop there, Abdul didn’t. He founded a successful student visa consultancy, which has already guided dozens of students from India, Bangladesh, and the Middle East in securing admissions and U.S. study visas. His business is currently expanding its international footprint and pursuing affiliations with ICEF and AIRC, reflecting strong credibility and professional growth.

“It’s hard to categorize someone like Mr. Khan, because he doesn’t fit in a box,” said Ms. Gautier. “What’s clear is that he leads with passion, integrity, and a mission to uplift those around him—whether they’re students, professionals, or fellow athletes.” On social media, where he has 12,000+ followers, Mr. Khan brings together his diverse expertise—offering fitness guidance, visa tips, and professional motivation to a broad, global audience. His voice resonates particularly with young people seeking permission to pursue multiple dreams without compromise.

In an increasingly siloed world, Mr. Abdul Hafeez Khan’s story is proof that you don’t need to choose between passions—you can master them all and change lives while doing it.

Media Contact
Company Name: Alpine Vision Media
Contact Person: Isabelle Gautier
Email: Send Email
Country: Switzerland
Website: https://alpinevisionmedia.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Rise of the Modern Polymath – Blending Technology, Fitness, and Business to Inspire a New Global Standard

The Secret of Sugarland: Engaging Children’s Book on Balanced Eating

Step into the world of The Secret of Sugarland, a heartwarming and imaginative journey by Dr. Haifa Hamdi. The Secret of Sugarland is more than just a story. It’s an invitation for young readers and families to explore a land where food choices shape the world around them.

With a blend of fun storytelling and real-life lessons, The Secret of Sugarland introduces a bright character, Ellie, a curious girl who loves sugary treats. Like many children, Ellie can visualize candies, cookies, and chocolates, but with great temptation comes great responsibility. Her adventures take a turn when she is swept into Sugarland – a place hidden amongst the clouds – where each bite has an even greater impact than she could ever imagine.

A Delightful Story with a Meaningful Message

The Secret of Sugarland story isn’t just about magical places and fun-loving characters. It’s a story meant to teach children about the beauty of balanced eating through natural and joyful means. Instead of preaching, the book allows kids to actively engage in the thrill of discovery with Ellie as she learns about how sugar affects her body and the world around her.

In Sugarland, we discover that Ellie meets Puffy, a friendly protector of the sky, who shares an urgent concern: the land is in danger since kids have been eating too much sugar on Earth. Their choices are causing Sugarland’s foundation to weaken, putting its lively creatures and beautiful landscapes at risk. Ellie soon realizes that making better food choices isn’t just about her own health—it’s about protecting something much bigger.

Why The Secret of Sugarland is a Must-read for Families

Haifa Hamdi has created an impressive book that is more than entertaining; it is captivating and significant for both children and their parents. Here is why this book deserves a spot on every child’s shelf:

• A Fun, Engaging Story – Kids pull into Ellie’s adventure, which is full of surprises, challenges, and memorable characters to vivify Sugarland.

• A Gentle Introduction to Healthy Eating – Rather than strict rules or heavy facts, the book naturally weaves in the importance of balanced food choices through storytelling.

• A Family Reading Experience – Perfect for bedtime reading or classroom discussions, it opens the door to conversations about food, habits, and making thoughtful decisions.

• A Message That Stays with You – While children will enjoy the story’s fun twists, the lessons of self-awareness and mindful eating will stick with them long after they’ve turned the last page.

Meet the Author: Haifa Hamdi

Dr. Haifa Hamdi is an innovative storyteller, a scientist, and a nutrition expert. She crafts stories that create a spark of curiosity and inspire young minds. With a science background and a concern for children’s healthy living, she blends education with creativity to make learning about nutrition exciting and engaging. The Secret of Sugarland is an incredible book for kids. This book is part of a mission that helps families cope with the ever-growing and ever-present temptation of sweets, candy, and so forth.

Get Your Copy Today!

The Secret of Sugarland is now available in stores and online! Gift it to a young reader for a fun and meaningful present, or enjoy this wonderful book that will turn mealtime conversation into an adventure. Order your copy today and take the first step into Sugarland!

Media Contact
Company Name: The Empire Publishers (USA)
Contact Person: Haifa Hamdi Ph.D.
Email: Send Email
Country: United States
Website: https://www.theempirepublishers.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Secret of Sugarland: Engaging Children’s Book on Balanced Eating

High Value Acquisition Completed to Substantially Strengthen Operations Structure and Seasoned Leadership of Advanced Video Compression Tech Company: Reticulate Micro, Inc. (Symbol: RMXI)

$RMXI Proprietary Platform Delivers High-Impact Results in Ultra-Low-Bandwidth Environments, Enabling Real-Time Video Where Traditional Solutions Fail

Video Technology Provider Focused on the Growing Global Demand for High Performance Video Data Transmission and Storage.

Optimized for Defense to AI and Enterprise Applications.

Military Applications Proven to Reduce Video Bandwidth, Storage and Power Consumption up to 50% with Quality Across Any Network or Hardware Platform.

VAST (Video Adaptive Systems Technology) Platform Delivers High-Impact Results in Ultra-Low-Bandwidth Environments Where Traditional Systems Fail.

Completed Acquisition of RMX Industries Inc. to Consolidate Operations and Expand Leadership Team.

Opened New VAST Research & Testing Facility (VRTF) Outside of Rochester, NY.

Plan to Launch its VAST Partner Program to Facilitate Technology Vendors and Solution Integrators for Video Compression Technology Into Their Products.

Plans to Release Significant Platform Enhancements in Early 2025, Including Advanced Dynamic Bandwidth Management and Adaptive Encoding Capabilities.

Comprehensive Integration Program Enabling Partners and Integrators to Embed VAST Directly into Their Product Lines and Government Contract Vehicles.

Reticulate Micro, Inc. (OTCQB: RMXI) is a video technology company focused on addressing the world’s growing crisis in video data transmission and storage. Through its proprietary VAST (Video Adaptive Systems Technology) platform, RMXI is aiming to transform how organizations capture, transmit, store and share visual data. The Company’s battle-tested technology, proven in military applications, reduces video bandwidth, storage, and power consumption by up to 50% while maintaining quality across any network or hardware platform. From defense to AI and enterprise applications, RMXI endeavors to redefine how organizations handle the growing demands of video data worldwide.

Reticulate Micro’s 2024 was defined by rapid technological advancements and rigorous market validation of its flagship VAST platform. Originally developed for government and defense applications, RMXI VAST delivered high-impact results in ultra-low-bandwidth environments, enabling real-time video where traditional solutions fail. Multiple military exercises and test events (over 20 in 2024) have proven RMXI VAST’s ability to stream video on any communication band, including narrow-band SATCOM, L-Band and even legacy HF networks where streaming video was thought to be unviable.

Building on its success in tactical video solutions for defense applications, RMXI is expanding its enterprise-level offerings for government and commercial customers. RMXI plans to release significant platform enhancements in early 2025, including advanced dynamic bandwidth management and adaptive encoding capabilities. Additionally, through its commercial joint venture launching in Q1 2025, RMXI is positioned to bring its revolutionary technology to global commercial markets.

The RMXI 2025 strategy centers on partner-focused growth and a platform-centric product roadmap:

Government Sector Partnership & OEM Integration

Strategic Partner Program: RMXI is launching a comprehensive integration program enabling partners and system integrators to embed VAST technology directly into their product lines and existing government contract vehicles.

Major Exercises & Evaluations: VAST has already been validated within U.S. Special Operations, multiple U.S. Army and Naval initiatives, and a range of international defense programs. This year’s schedule includes high-profile exercises with U.S. SOCOM, Army, and Navy, as well as several invitations specifically created for VAST testing and evaluation.

Commercial Scale via Joint Venture (RMX and CRISP)

Global Managed Services: RMXI partnered with K2 Endeavor DMCC to form RMX, a joint venture company building upon VAST and branded as “CRISP” (Compressed Rate Intelligent Streaming Protocol) for commercial and enterprise verticals—from telecommunications to security camera networks.

Recurring Revenue Model: RMX’s global managed service structure is designed to offer predictable, long-term revenue while solving critical video-delivery challenges for enterprise customers.

Expanded Product Suite

VAST Video Encoder: The core software-based video encoder product will see the addition of key features including audio, KLV metadata support, video tele-conferencing, and region of interest encoding.

VAST Vue: Cross-platform (Windows, Linux, Mac OS, Android, iOS) video player for seamless end-to-end experiences, including support for tactical metadata.

VAST SDK: Development tools and APIs for advanced integration of core VAST capabilities into partner products and solutions.

VAST VUDO: An advanced combination of VAST’s video streaming capabilities with advanced mapping and sensor data integration to provide enhanced situational awareness in disconnected and austere environments.

VAST Cloud: VAST-as-a-Service cloud offering for enterprise solutions, including live streaming, transcoding and VOD (video on demand) services.

Acquisition of Remaining RMX Industries Inc. Shares to Consolidate Operations and Expand Leadership Team

On April 23rd RMXI announced that it has acquired the remaining shares of RMX Industries Inc., the Company’s 50/50 joint venture company with K2 Endeavor DMCC, through a stock exchange transaction, making it a wholly-owned subsidiary. The move consolidates operations and aligns resources to accelerate commercial business opportunities across key sectors.

As part of this strategic consolidation, RMXI also announced important changes to its governance and management teams:

M.Steven Kirchof has been appointed as an independent member of the RMXI board of directors. Mr. Kirchof has over 20 years of experience building entrepreneurial companies and driving innovation in healthcare technology. Mr. Kirchof is the CEO of CureGrail, Inc., a healthcare technology company engaging and empowering patients to own and manage their disease, and founder and CEO of RxPath, LLC, a healthcare transaction company. Mr. Kirchof previously co-founded Matrix Oncology and served in executive, sales management, marketing, and strategy leadership positions at iKnowMed, Inc., MedStat Group, and IBM Healthcare.

Karl Kit has been appointed as RMXI Chief Executive Officer, President and as a member of the board of directors. Mr. Kit is a seasoned entrepreneur with over 40 years of international business experience across advertising, communications, mobile data services, and financial technology. Mr. Kit previously headed K2 Endeavor DMCC, a UAE-based strategic investment group.

Andrew Sheppard has been appointed as President of RMX Government. Mr. Sheppard will lead RMXI efforts in the defense and government sectors, focusing on deploying its cutting-edge video and data compression technologies to meet the mission-critical needs of military and public safety customers. Mr. Sheppard previously served as the Company’s Chief Executive Officer and President.

Maxwell Kit has been appointed as RMXI Chief Marketing Officer. Mr. Kit has extensive experience in global brand strategy, digital engagement, and go-to-market execution. As CMO, he will lead RMX’s marketing and communications efforts, refine the RMXI brand identity, and expand market visibility. Mr. Kit will oversee the launch of integrated campaigns that highlight the transformative power of RMXI proprietary compression technology across defense, AI, telecommunications, and enterprise sectors.

Opening of VAST Research & Testing Facility

On March 17th RMXI announced the opening of its state-of-the-art VAST Research & Testing Facility (VRTF) outside of Rochester, NY. The facility covers dozens of acres and is capable of hosting real-life scenarios involving various tactical radio communication networks with manned/unmanned vehicles. RMXI expects the facility to accelerate the adoption of VAST’s video compression technology by government programs and facilitate its uptake by tactical communications network vendors.

VAST is a groundbreaking software-based video encoder platform, the first ever able to stream video over HF radio. Unlike traditional video encoder systems, VAST can operate on most x86 or Arm computing platform – from servers to low-SWaP (size, weight, and power) single-board computers. Its ability to enable video in bandwidth and resource-constrained tactical networks has opened a myriad of opportunities for video applications in scenarios and use cases where they were previously impossible.

VAST Partner Program

On March 3rd RMXI announced plans for its VAST Partner Program. The program will facilitate technology vendors and solution integrators to incorporate VAST’s groundbreaking video compression technology into their products and offerings.

The RMXI VAST Partner Program will include a dedicated partner manager who works closely with participants throughout the integration to commercialization process. Partners will receive engineering toolkits, demonstration resources, and technical consulting to accelerate time-to-market. The program will also offer early access to new features, input into product roadmaps, and collaborative marketing opportunities. Importantly, the program is available to all qualified companies interested in exploring VAST’s capabilities.

For more information on $RMXI visit www.reticulate.io

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Media Contact
Company Name: Reticulate Micro, Inc.
Contact Person: Reticulate Micro Media Relations
Email: Send Email
Phone: 866-70 MICRO
Address:4220 Duncan Ave, Suite 201
City: St. Louis
State: Missouri 63110
Country: United States
Website: www.reticulate.io

Shore Homecare Services Expands Life-Enriching In-Home Care for Seniors in Toms River, NJ

Dedicated to supporting families with exceptional home care solutions tailored to enhance seniors’ quality of life in Toms River, NJ.

Toms River, NJ – Shore Homecare Services continues its mission to elevate senior well-being by offering enhanced in-home care services to Toms River, NJ residents. This initiative recognizes the growing need for compassionate and professional support for seniors and ensures families can access trusted care providers who prioritize their loved one’s dignity and independence.

“In-home care isn’t just a service; it’s a lifeline for families seeking comfort, support, and reliability for their aging loved ones,” said Fernando Reinoso, owner of Shore Homecare Services. “Our commitment to the Toms River community is to provide tailored, high-quality home care that allows seniors to live fulfilling lives within the comfort of their homes. This initiative underscores our belief that seniors deserve the opportunity to age gracefully and safely with the support they need.”

Home care services are critical in empowering seniors to maintain independence while addressing their physical and emotional needs. For individuals facing challenges such as mobility limitations, chronic conditions, or cognitive decline, personalized care ensures they receive the attention necessary to thrive. These services reduce the risk of hospital readmissions and foster emotional well-being by allowing seniors to remain in a familiar and comforting environment.

Moreover, home care provides a much-needed support system for family members, offering peace of mind while alleviating the stress and responsibilities of caregiving. Professional caregivers can assist with a wide range of tasks, from daily activities like meal preparation and hygiene to more specialized health-related care, giving families the confidence that their loved ones are in capable hands.

Beyond meeting immediate needs, home care creates opportunities for meaningful connections and companionship, vital for seniors’ mental health. These services contribute to improved quality of life and a stronger sense of purpose, reinforcing the importance of personalized, in-home solutions for the aging population.

Shore Homecare Services’ tailored solutions range from assistance with daily living activities to more complex health care needs, ensuring each individual receives personalized and professional care. With this initiative, families can alleviate stress while ensuring the health, safety, and happiness of their loved ones in Toms River, NJ.

To learn more about Shore Homecare Services and their home care in Toms River, NJ, please visit their website at https://shorehomecareservices.com.

About Shore Homecare Services:

Shore Homecare Services is a leading provider of senior in-home care solutions in Toms River, NJ. Devoted to enhancing the lives of seniors and their families, they offer compassionate, professional care tailored to meet diverse needs. From daily assistance to specialized health services, Shore Homecare Services ensures every senior receives care rooted in respect and trust.

Media Contact
Company Name: Shore Homecare Services
Contact Person: Fernando Reinoso
Email: Send Email
Phone: +1 732 534 5000
Address:19 N County Line Rd Suite #13
City: Jackson Township
State: NJ
Country: United States
Website: https://shorehomecareservices.com

Retinopathy of Prematurity Market is Expected to Witness Significant Growth from USD 13 Million in 2023, Driven by Advancements in Treatment Options | DelveInsight

“Retinopathy of Prematurity treatment market report DelveInsight”

The Retinopathy of Prematurity treatment market is expected to witness significant growth in the coming years, primarily driven by advancements in diagnostic technologies and the development of novel therapeutics by key players such as Novartis, Regeneron, Bayer, FeliQS Corporation, and Infant Bacterial Therapeutics, among others. This growth trajectory is further supported by the rising awareness, improvements in neonatal care units, and increasing focus on preventive approaches.

DelveInsight’s “Retinopathy of Prematurity Market Insight, Epidemiology And Market Forecast – 2034” report delivers an in-depth understanding of ROP, historical and forecasted epidemiology, as well as the therapeutic market trends in the 7MM which include the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. The retinopathy of prematurity market size in the 7MM was approximately USD 13 million in 2023, with the US accounting for approximately USD 8 million of this value. The ROP market is expected to grow steadily during the forecast period (2024-2034), driven by the introduction of novel therapies, advancements in neonatal care, increasing awareness of the importance of early eye examinations for premature infants, and the rising prevalence of premature births.

Download the Retinopathy of Prematurity Market report to understand which factors are driving the retinopathy of prematurity therapeutic market @ Retinopathy of Prematurity Market Trends.

According to DelveInsight’s analysis, the total number of incident cases of preterm infants by birth weight (≤1,500g) in the 7MM was approximately 94K in 2023, with these cases anticipated to increase during the study period of 2020-2034. Interestingly, there is a decreasing trend in preterm births (≤1,500g) in Germany, Italy, and Spain. Among the EU4 countries, Germany accounted for the highest number of incident cases of ROP, followed by France, whereas Spain had the lowest number of cases in 2023. Japan reported approximately 5K incident cases of ROP in 2023, with this number expected to rise during the forecast period.

Discover evolving trends in the retinopathy of prematurity patient pool forecasts @ Retinopathy of Prematurity Epidemiology Analysis.

The report also explores the current and evolving retinopathy of prematurity treatment landscape. The current ROP treatment landscape primarily relies on laser therapy, which generated the highest revenue in the 7MM in 2023. Laser therapy has emerged as the standard of care aimed at countering the overproduction of vascular endothelial growth factor (VEGF) within the retina, a key factor contributing to the condition.

Anti-VEGF agents have become particularly valuable for infants for whom laser photocoagulation is difficult or impossible. Currently, there are only two retinopathy of prematurity approved drugs: EYLEA by Regeneron (NASDAQ: REGN)/Bayer (ETR: BAYN) and LUCENTIS by Novartis (SWX: NOVN). LUCENTIS is a humanized, high-affinity antibody fragment that binds to VEGF-A, while EYLEA is a VEGF inhibitor designed to block the growth of new blood vessels by targeting both VEGF-A and placental growth factor.

A notable treatment pattern observed is that only approximately 10% of the total ROP patients in the US and European countries, representing the severe and treatable pool, undergo any kind of treatment. In contrast, approximately 30% of ROP patients in Japan receive treatment, suggesting a more aggressive approach to management in this region. This difference highlights the variation in clinical practice across different healthcare systems, with Japanese ophthalmologists likely treating infants at an earlier stage of ROP compared to other countries.

The ROP pipeline is currently in the early stages of development, with most candidates focusing on preventive approaches rather than treatment. Key players such as FeliQS Corporation and Infant Bacterial Therapeutics (STO: IBT-B) are developing FLQ-101 and IBP-1118, respectively, both currently in preclinical stages for the retinopathy of prematurity prevention. In a significant development, the FDA granted Fast Track designation to FLQ-101 in November 2024, highlighting the recognition of unmet needs in this therapeutic area. FeliQS raised USD 2.5 million in 2022 to conduct pre-IND meetings with the FDA and manufacture the investigational drug, with a Phase 1b/2 study in both the US and Japan in the first quarter of 2025. In 2024, FLQ-101 also received Orphan Drug designation from the FDA.

Recent developments in the ROP market include the FDA’s acceptance in February 2025 of Alvotech’s biologics license application (BLA) for AVT06, a proposed biosimilar to EYLEA (Regeneron). Regulatory approval is expected to be completed in the fourth quarter of 2025, potentially expanding treatment options and improving accessibility.

Unlock which retinopathy of prematurity emerging drug is expected to capture the largest market share in 7MM by 2034. Visit the Retinopathy of Prematurity Drug Insights.

Looking ahead, the ROP market is expected to grow due to the development of better screening tools, the introduction of preventive treatments, and increased awareness about early detection. New treatment approaches for Retinopathy of Prematurity (ROP) aim to be faster and more efficient, allowing doctors to treat babies directly in local neonatal intensive care units (NICUs) without lengthy procedures or specialized anesthesia. These newer methods are expected to be more effective than traditional laser treatment, which, while helpful, can be stressful and time-consuming. Anti-VEGF drugs like EYLEA offer a quicker, FDA-approved alternative that can be given at the bedside without needing general anesthesia or costly laser equipment.

As research reveals more about the causes of ROP, new treatment options are likely to emerge, potentially changing how this serious eye condition is managed in vulnerable newborns.

Table of Contents

1. Key Insights

2. Report Introduction

3. Executive Summary of Retinopathy of Prematurity

4. Key Events

5. Retinopathy of Prematurity Epidemiology and Market Forecast Methodology

6. Retinopathy of Prematurity Market Overview at a Glance

7. Disease Background and Overview

8. Epidemiology and Patient Population of the 7MM

9. Retinopathy of Prematurity Patient Journey

10. Retinopathy of Prematurity Marketed Drugs

11. Key Competitors for Pre-clinical Assets

12. Retinopathy of Prematurity: 7MM Analysis

13. Retinopathy of Prematurity Unmet Needs

14. SWOT Analysis

15. KOL Views

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

Retinopathy Of Prematurity Pipeline Insight provides comprehensive insights about the retinopathy of prematurity pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the retinopathy of prematurity companies, including Novartis, Regeneron, and Bayer, among others.

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Retinopathy of Prematurity Market is Expected to Witness Significant Growth from USD 13 Million in 2023, Driven by Advancements in Treatment Options | DelveInsight

Tongue Cancer Treatment Market Set for Significant Growth Through 2032 | DeveInsight

“Tongue Cancer Treatment Market Report DelveInsight”

The tongue cancer market is projected to experience considerable growth by 2032. Key tongue cancer therapeutic players include Modra Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb Company, Cipla Inc., Eli-Lilly, F. Hoffmann-La Roche, Fresenius Kabi AG, Intas Pharmaceuticals Ltd., MERCK & CO. INC., VIATRIS INC., Sanofi S.A., Teva Pharmaceuticals Industries Ltd, GSK, Novartis, Pfizer and Orca Healthcare, among others.

DelveInsight’s “Tongue Cancer – Market Insight, Epidemiology and Market Forecast – 2032” report provides a detailed analysis of market trends, epidemiological patterns, and therapeutic development across the 7MM. The Tongue Cancer Market is experiencing significant growth with a decent CAGR during 2019-2032. The US dominates the tongue cancer treatment market among 7MM, and this trend is expected to continue during the forecasted period. Increasing awareness and diagnosis, advancements in targeted therapies with improved treatment outcomes and reduced side effects, and an increasing tongue cancer patient pool are some of the factors responsible for this growth.

Download the Tongue Cancer Market report to understand which factors are driving the tongue cancer therapeutic market @ Tongue Cancer Market Trends.

The epidemiological analysis in the report reveals important trends in the tongue cancer patient pool across the 7MM. Historical data and forecasted patterns suggest changing demographics and risk factor profiles among affected populations. While tongue cancer has typically been more common in males, the report suggests that the overall male-to-female ratio for tongue cancer is decreasing due to changing habits and lifestyle factors. This indicates a potential shift in tongue cancer epidemiology.

Discover evolving trends in the tongue cancer patient pool forecasts @ Tongue Cancer Epidemiology Analysis.

This report also offers a comprehensive assessment of current tongue cancer treatment practices and emerging therapies with clinical trial updates and FDA approvals. The tongue cancer treatment market has historically been dominated by conventional approaches, including surgery, radiation therapy, and chemotherapy, with recent years showing promising developments in targeted and immunotherapeutic interventions.

Chemotherapy agents such as docetaxel (Sanofi-Aventis), cisplatin, and 5-fluorouracil (GLS PHARMA LTD) demonstrated an excellent response rate for tongue cancer treatment. Targeted therapies have gained prominence, with cetuximab (Erbitux) being a key player in tongue cancer. Recently, immunotherapy has revolutionized the tongue cancer treatment landscape, with KEYTRUDA (MRK) and OPDIVO (Bristol Myers Squibb) approved for use in head and neck cancer, including tongue cancer.

There are several emerging therapies that target various molecular pathways and are designed to overcome the limitations of existing treatments, potentially offering improved efficacy, reduced toxicity profiles, and enhanced quality of life for patients.

APG-157 (Aveta Biomics), a novel botanical drug derived from Curcuma longa (turmeric), is under investigation for tongue cancer as part of head and neck squamous cell carcinoma clinical trials (NCT05312710). Another drug, HB 202 (Hookipa Pharma), is being evaluated in clinical trials for HPV16-positive tongue cancer. The report analyzes these emerging drugs and several others based on their development stage, mechanism of action, route of administration, and potential market impact upon launch.

Innovative combination treatments, such as pairing cisplatin with agents like plumbagin, have also shown promise in enhancing anticancer efficacy and reversing resistance in tongue squamous cell carcinoma. This approach works by increasing intracellular reactive oxygen species and modulating key signaling pathways.

EMI-137, a fluorescent tracer that targets the c-MET receptor, is currently undergoing phase II trials to evaluate its feasibility for visualizing tumor margins and lymph node metastases during surgery. The goal is to enhance tumor detection and reduce the risk of incomplete resection. Early pilot studies have demonstrated that intravenous administration of EMI-137 allows for real-time intraoperative visualization of tongue tumors, potentially facilitating more precise and less invasive surgical procedures.

Tophill Trial, a randomized controlled clinical trial for locally advanced resectable oral squamous cell carcinoma, including tongue cancer, is showing positive results as of September 2024. In January 2025, tongue cancer research unveiled critical insights into chemotherapy resistance. The research revealed that tongue cancer cells activate autophagy and cholesterol biosynthesis pathways to enter a chemotherapy-resistant state, allowing MRD to persist and drive recurrence. Recent developments like these highlight the growing interest in tongue cancer research and the potential growth opportunities in the landscape.

Unlock which tongue cancer emerging drug is expected to capture the largest market share in 7MM by 2034. Visit the Tongue Cancer Drug Insights.

Despite the promising outlook, the tongue cancer market faces several challenges, including increasing treatment costs, side effects of current therapies, and the need for more effective options for advanced or recurrent tongue cancer. Additionally, reimbursement complexities across different healthcare systems pose significant barriers to market access for novel therapies.

The key driving factors include increasing disease awareness, improving diagnostic capabilities, and rising healthcare expenditure across developed and developing economies. The report suggests that the United States represents the largest share of the tongue cancer market, followed by the EU5 countries and Japan, with each region exhibiting unique market characteristics influenced by healthcare infrastructure, reimbursement policies, and treatment guidelines.

In conclusion, the tongue cancer market faces several challenges, such as high treatment costs, side effects from current therapies, and the need for more effective options for advanced or recurrent cases. Additionally, the complexities of reimbursement across various healthcare systems create significant barriers to market access for novel therapies. However, several factors are driving market growth, including technological advancements in diagnostic techniques, an increasing geriatric population, a rising prevalence of risk factors like tobacco and alcohol consumption, and growing investments in research and development by leading pharmaceutical companies. These elements collectively contribute to the anticipated expansion of the tongue cancer market through 2032, creating substantial opportunities for stakeholders across the healthcare ecosystem.

Table of Contents: